QRP Research BPC-157 + TB-500 20mg
BPC-157 + TB-500 is a dual-peptide research blend combining two distinct synthetic peptides that have been independently investigated in experimental models involving cellular repair mechanisms, tissue remodelling, angiogenesis-related signalling and cytoskeletal biology.
The formulation combines BPC-157, a synthetic 15-amino-acid pentadecapeptide, with TB-500, a research peptide associated with the actin-binding region of Thymosin Beta-4 (Tβ4).
Although these compounds are frequently studied within similar areas of experimental research, they are structurally and biologically distinct molecules and should not be considered interchangeable.
BPC-157 Research Profile
BPC-157 is a synthetic pentadecapeptide that has been investigated predominantly in laboratory and animal models.
Experimental research involving BPC-157 has examined mechanisms associated with cell migration, angiogenesis-related signalling, nitric oxide pathways, vascular responses and connective-tissue biology.
Research has also explored interactions involving VEGF/VEGFR-associated signalling, cellular migration and various molecular pathways involved in experimental tissue-response models.
TB-500 Research Profile
TB-500 is associated with the biologically active actin-related region of Thymosin Beta-4, a naturally occurring peptide involved in cytoskeletal organisation and cellular movement.
Actin plays a fundamental role in cell shape, migration, division and structural organisation, making TB-500 and related Thymosin Beta-4-derived peptides of interest in experimental research involving cytoskeletal dynamics and cellular migration.
TB-500-related research has therefore focused on mechanisms involving actin regulation, cell motility, endothelial-cell behaviour and tissue-remodelling pathways.
Dual-Peptide Research
Combining BPC-157 and TB-500 provides researchers with a formulation containing two distinct research peptides associated with different molecular pathways.
BPC-157 research has focused substantially on signalling-level mechanisms involving vascular and cellular responses, while TB-500-related research has focused more strongly on actin-associated cytoskeletal processes and cellular migration.
The theoretical scientific interest in studying these compounds together therefore arises from their different biological mechanisms rather than molecular similarity.
Importantly, research on the combined formulation remains limited. Findings from studies investigating either BPC-157 or TB-500 individually should not automatically be interpreted as evidence of additive or synergistic effects when the compounds are combined.
Key Research Areas
BPC-157 and TB-500 have been investigated experimentally in relation to:
- Cellular migration and motility
- Cytoskeletal organisation and actin dynamics
- Angiogenesis-related signalling
- Endothelial-cell biology
- Connective-tissue research
- Extracellular matrix remodelling
- Cellular repair-response mechanisms
- Nitric oxide-associated signalling
- VEGF / VEGFR-related pathways
- Inflammatory signalling mechanisms
- Tissue-remodelling pathways
- Peptide-mediated cellular signalling
- Thymosin Beta-4 structure-function research
Research involving BPC-157, TB-500 and their combination remains predominantly preclinical. Findings should not be interpreted as evidence of established injury-recovery, tissue-healing, performance-enhancing or therapeutic effects in humans.
Product Specification
Product: BPC-157 + TB-500 Research Blend
Compounds: BPC-157 / TB-500
Compound Type: Dual synthetic peptide research formulation
BPC-157 Content: 10mg
TB-500 Content: 10mg
Total Peptide Content: 20mg
Form: Lyophilised research material
Primary Research Areas: Cellular Signalling / Cytoskeletal Biology / Tissue Remodelling
Brand: QRP Research
Application: Laboratory and scientific research
Why QRP Research?
QRP Research supplies specialist research materials with an emphasis on quality, consistency and traceability. Products are securely packaged and clearly identified for their intended laboratory application.
Storage
Store in a cool, dry and dark environment, protected from excessive heat, direct light and moisture.
Appropriate laboratory storage procedures should be followed to preserve the stability and integrity of the research material.
Research Use Notice
FOR RESEARCH USE ONLY.
This product is supplied exclusively for laboratory, analytical and scientific research.
- NOT for human consumption or administration.
- NOT for animal consumption or administration.
- NOT a medicine, food supplement or cosmetic product.
- NOT intended to diagnose, treat, cure or prevent any disease.
- No human dosing or administration instructions are provided.
- Intended to be handled only by appropriately qualified researchers or laboratory professionals.
QRP Research BPC-157 + TB-500 20mg is supplied strictly as a research material for non-clinical laboratory investigation.
QRP Research BPC-157 + TB-500 (Wolverine Blend) 20mg
Spend More, Get More






























